Infertility Drugs Market: Size, Share, Industry Growth | 2022-2027
Market Overview 2022-2027:
According to the global infertility drugs market report by IMARC Group, the market reached a value of US$ 3.47 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.95 Billion by 2027 exhibiting a CAGR of 5.70% during 2022-2027.
Industry Definition and Application:
Infertility drugs are medicines used to cure infertility and improve the reproductive health of an individual. They are either consumed orally or injected to enhance the quality of sperm and restore the testosterone level in males. In contrast, they stimulate ovulation and follicle development of the ovary in females.
Request a PDF Sample Copy for more detailed market insights: https://www.imarcgroup.com/infertility-drugs-market/requestsample
Market Trends:
One of the primary factors driving the market is the rising prevalence of infertility, miscarriage, polycystic ovary syndrome (PCOS) cases, breast and urinary cancers, diabetes, obesity and thyroid. Additionally, the sedentary lifestyles and delayed pregnancies are declining the fertility rates, thus propelling the market growth. Besides this, the consumption of alcohol, drugs and smoking is accelerating the adoption rates.
Furthermore, extensive investment in the research and development (R&D) activities and various initiatives taken by governments of different nations to spread awareness about the availability of these treatments are escalating the product demand. Moreover, rising public funding for developing these drugs and rapid approvals from regulatory bodies are creating a positive market outlook. Several other growth-inducing factors include the expanding healthcare industry, rising disposable income levels, technological upgradations, rapid urbanization, and increasing demand for generic medicines.
Click here to view detailed information with table of content: https://bit.ly/3NyUphc
Key Market Segmentation:
The report has segmented the market on the basis of region, drug class, route of administration, distribution channel and end user.
Breakup by Drug Class:
- Gonadotropin
- Aromatase Inhibitors
- Selective Estrogen Receptor Modulators (SERMs)
- Biguanides
- Others
Breakup by Route of Administration:
- Oral
- Intravenous
- Subcutaneous
- Intramuscular
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Breakup by End User:
- Male
- Female
Breakup by Geography:
- North America:( United States, Canada)
- Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- Bayer AG
- Mankind Pharma
- Merck & Co. Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Ferring Pharmaceuticals
- Livzon Pharmaceutical Group Inc.
- Sanofi S.A.
- Theramex.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Phone: +1-631-791-1145
Address:30 N Gould St Ste R
City: Sheridan
State: WY
Country: United States
Website: https://www.imarcgroup.com
English
Arabic
Français
Español
Português
Deutsch
Dutch
Italiano
Russian
Romaian